arrow
D

Denisa Bogdan

The Institute of Cancer Research
H指数:10
被引数:822

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “B7-H3 as a Therapeutic Target in Advanced Prostate Cancer” [European Urology 83 (2023) 224–238

勘误:“B7-H3 作为晚期前列腺癌的治疗靶点” [欧洲泌尿外科杂志 83 (2023) 224–238]

2026-08-070
OAAI
Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer

开发针对MCL1和BCLXL的致死性前列腺癌的治疗策略

2025-11-100
OAAI
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer

阐明靶向MCL1的分子分层单药及联合治疗策略,以治疗致命性前列腺癌

2025-10-080
OAAI
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
2024-09-170
OAAI
AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
2024-09-130
OAAI
RNASEH2B loss and PARP inhibition in advanced prostate cancer
2024-06-040
OAAI
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer
2024-02-272
OAAI
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer
2023-11-155
OAAI
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

靶向髓系趋化逆转前列腺癌治疗耐药

Nature
IF48.5
2023-10-160
OAAI
BCL2 expression is enriched in AR-independent advanced prostate cancer
2023-06-021
PRE
B7-H3 as a Therapeutic Target in Advanced Prostate Cancer (vol 83, pg 224, 2023)

B7-H3作为晚期前列腺癌的治疗靶点 (第83卷,224页,2023页)

2023-06-011
OA
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
2023-02-0129
OAAI
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

一种非编码RNA平衡行为: miR-346-induced DNA损伤受前列腺癌中长链非编码RNA NORAD的限制

2022-03-2216
OAAI